Compare State Street SPDR S&P Biotech ETF (XBI) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs State Street PDR S&P Retail ETF — how do they compare? State Street SPDR S&P Biotech ETF trades at $159.01, while State Street PDR S&P Retail ETF trades at $88.73. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, State Street PDR S&P Retail ETF nearer its low. Which is the better fit depends on your goals.
| XBI | XRT | |
|---|---|---|
Sector | Broad Market / Factor | Broad Market / Factor |
52-Week High | $164.28 | $92.35 |
52-Week Low | $86.92 | $77.28 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XBI trades at $159.15, up 0.71% with a bullish technical signal from moving averages. The biotech ETF shows strong momentum with a 17% monthly gain, driven by positive clinical data and M&A activity. Analyst coverage remains limited with a single hold rating, while institutional interest grows with recent $793,000 investment from Bay Colony Advisors.
Outlook remains positive given biotech sector resurgence, though elevated RSI suggests near-term overbought conditions. Key risks include sector volatility and regulatory uncertainty, but AI-driven drug discovery and strong pipeline developments provide growth catalysts for patient investors.
XRT trades at $88.81, down 1.96% today, with a bullish technical signal from moving averages and key indicators like ADX suggesting a strong trend. The ETF's valuation metrics are not available in the provided data, but recent news highlights retail sector focus amid mixed economic signals. A dividend of $0.19 is scheduled for June 2026, adding income potential.
The outlook for XRT is cautiously optimistic, driven by positive retail sales trends and potential Fed easing, but risks include consumer sentiment pressures and inflation. Analyst sentiment is mixed, with some downgrades citing macro headwinds, making it essential to monitor economic indicators for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
